<DOC>
	<DOC>NCT02439385</DOC>
	<brief_summary>Oral curcumin-containing supplement will be given to colorectal cancer patients with unresectable metastases who will be starting Avastin/FOLFIRI chemotherapy for up to completion of (or withdrawal from) chemotherapy.</brief_summary>
	<brief_title>Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Age : 20 Years and older Histologically confirmed adenocarcinoma of the colon or rectum Patients with primary colon or rectal cancer and unresectable metastatic lesions. Patients with no primary cancer related symptoms. ECOG performance status of 0 2 Appropriate organ functions (hepatic transaminases less than 5 times the normal range; bilirubin less than 2 times the normal range; creatinine serum less than 1.5 times the normal range; thrombocyte more than 100,000/µl; neutrophil more than 1,500/µl) ASA score of &lt; 3 An informed consent form has been signed by the patient. Colorectal cancer other than adenocarcinoma The patient received adjuvant chemotherapy within the past 6 months. The patient received chemotherapy for metastatic colon cancer. The patient was planning to have curative surgery for the metastatic lesions. Patients with peritoneal carcinomatosis. Patients with primary tumor related complications such as intestinal obstruction, intractable bleeding, and perforation, that needs to be treated. ASA score of &gt; 4 The patient has chronic hepatitis or cirrhosis. An asymptomatic HBV or HCV carrier can participate. Patients with an active infection, which need antibiotic therapy, during the randomization period. Pregnant or breastfeeding women Patients with another different malignant tumor during the past 5 years. Patients with treated nonmelanoma skin cancer or cervical cancer can be enrolled in this study.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Curcumin</keyword>
	<keyword>Avastin</keyword>
	<keyword>FOLFIRI</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Unresectable metastasis</keyword>
</DOC>